Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry.

Bigdeli TB, Genovese G, Georgakopoulos P, Meyers JL, Peterson RE, Iyegbe CO, Medeiros H, Valderrama J, Achtyes ED, Kotov R, Stahl EA, Abbott C, Azevedo MH, Belliveau RA, Bevilacqua E, Bromet EJ, Byerley W, Carvalho CB, Chapman SB, DeLisi LE, Dumont AL, O'Dushlaine C, Evgrafov OV, Fochtmann LJ, Gage D, Kennedy JL, Kinkead B, Macedo A, Moran JL, Morley CP, Dewan MJ, Nemesh J, Perkins DO, Purcell SM, Rakofsky JJ, Scolnick EM, Sklar BM, Sklar P, Smoller JW, Sullivan PF, Macciardi F, Marder SR, Gur RC, Gur RE, Braff DL; Consortium on the Genetics of Schizophrenia (COGS) Investigators, Nicolini H, Escamilla MA, Vawter MP, Sobell JL, Malaspina D, Lehrer DS, Buckley PF, Rapaport MH, Knowles JA; Genomic Psychiatry Cohort (GPC) Consortium, Fanous AH, Pato MT, McCarroll SA, Pato CN.

Mol Psychiatry. 2019 Oct 7. doi: 10.1038/s41380-019-0517-y. [Epub ahead of print]

PMID:
31591465
2.

Genome-wide association study identifies 30 loci associated with bipolar disorder.

Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, Pers TH, Holmans PA, Richards AL, Abbott L, Agerbo E, Akil H, Albani D, Alliey-Rodriguez N, Als TD, Anjorin A, Antilla V, Awasthi S, Badner JA, Bækvad-Hansen M, Barchas JD, Bass N, Bauer M, Belliveau R, Bergen SE, Pedersen CB, Bøen E, Boks MP, Boocock J, Budde M, Bunney W, Burmeister M, Bybjerg-Grauholm J, Byerley W, Casas M, Cerrato F, Cervantes P, Chambert K, Charney AW, Chen D, Churchhouse C, Clarke TK, Coryell W, Craig DW, Cruceanu C, Curtis D, Czerski PM, Dale AM, de Jong S, Degenhardt F, Del-Favero J, DePaulo JR, Djurovic S, Dobbyn AL, Dumont A, Elvsåshagen T, Escott-Price V, Fan CC, Fischer SB, Flickinger M, Foroud TM, Forty L, Frank J, Fraser C, Freimer NB, Frisén L, Gade K, Gage D, Garnham J, Giambartolomei C, Pedersen MG, Goldstein J, Gordon SD, Gordon-Smith K, Green EK, Green MJ, Greenwood TA, Grove J, Guan W, Guzman-Parra J, Hamshere ML, Hautzinger M, Heilbronner U, Herms S, Hipolito M, Hoffmann P, Holland D, Huckins L, Jamain S, Johnson JS, Juréus A, Kandaswamy R, Karlsson R, Kennedy JL, Kittel-Schneider S, Knowles JA, Kogevinas M, Koller AC, Kupka R, Lavebratt C, Lawrence J, Lawson WB, Leber M, Lee PH, Levy SE, Li JZ, Liu C, Lucae S, Maaser A, MacIntyre DJ, Mahon PB, Maier W, Martinsson L, McCarroll S, McGuffin P, McInnis MG, McKay JD, Medeiros H, Medland SE, Meng F, Milani L, Montgomery GW, Morris DW, Mühleisen TW, Mullins N, Nguyen H, Nievergelt CM, Adolfsson AN, Nwulia EA, O'Donovan C, Loohuis LMO, Ori APS, Oruc L, Ösby U, Perlis RH, Perry A, Pfennig A, Potash JB, Purcell SM, Regeer EJ, Reif A, Reinbold CS, Rice JP, Rivas F, Rivera M, Roussos P, Ruderfer DM, Ryu E, Sánchez-Mora C, Schatzberg AF, Scheftner WA, Schork NJ, Shannon Weickert C, Shehktman T, Shilling PD, Sigurdsson E, Slaney C, Smeland OB, Sobell JL, Søholm Hansen C, Spijker AT, St Clair D, Steffens M, Strauss JS, Streit F, Strohmaier J, Szelinger S, Thompson RC, Thorgeirsson TE, Treutlein J, Vedder H, Wang W, Watson SJ, Weickert TW, Witt SH, Xi S, Xu W, Young AH, Zandi P, Zhang P, Zöllner S; eQTLGen Consortium; BIOS Consortium, Adolfsson R, Agartz I, Alda M, Backlund L, Baune BT, Bellivier F, Berrettini WH, Biernacka JM, Blackwood DHR, Boehnke M, Børglum AD, Corvin A, Craddock N, Daly MJ, Dannlowski U, Esko T, Etain B, Frye M, Fullerton JM, Gershon ES, Gill M, Goes F, Grigoroiu-Serbanescu M, Hauser J, Hougaard DM, Hultman CM, Jones I, Jones LA, Kahn RS, Kirov G, Landén M, Leboyer M, Lewis CM, Li QS, Lissowska J, Martin NG, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Melle I, Metspalu A, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Neale BM, Nimgaonkar V, Nordentoft M, Nöthen MM, O'Donovan MC, Oedegaard KJ, Owen MJ, Paciga SA, Pato C, Pato MT, Posthuma D, Ramos-Quiroga JA, Ribasés M, Rietschel M, Rouleau GA, Schalling M, Schofield PR, Schulze TG, Serretti A, Smoller JW, Stefansson H, Stefansson K, Stordal E, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Werge T, Nurnberger JI, Wray NR, Di Florio A, Edenberg HJ, Cichon S, Ophoff RA, Scott LJ, Andreassen OA, Kelsoe J, Sklar P; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium.

Nat Genet. 2019 May;51(5):793-803. doi: 10.1038/s41588-019-0397-8. Epub 2019 May 1.

3.

Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases.

Charney AW, Stahl EA, Green EK, Chen CY, Moran JL, Chambert K, Belliveau RA Jr, Forty L, Gordon-Smith K, Lee PH, Bromet EJ, Buckley PF, Escamilla MA, Fanous AH, Fochtmann LJ, Lehrer DS, Malaspina D, Marder SR, Morley CP, Nicolini H, Perkins DO, Rakofsky JJ, Rapaport MH, Medeiros H, Sobell JL, Backlund L, Bergen SE, Juréus A, Schalling M, Lichtenstein P, Knowles JA, Burdick KE, Jones I, Jones LA, Hultman CM, Perlis R, Purcell SM, McCarroll SA, Pato CN, Pato MT, Di Florio A, Craddock N, Landén M, Smoller JW, Ruderfer DM, Sklar P.

Biol Psychiatry. 2019 Jul 15;86(2):110-119. doi: 10.1016/j.biopsych.2018.12.009. Epub 2018 Dec 20.

PMID:
30686506
4.

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.

Charney AW, Ruderfer DM, Stahl EA, Moran JL, Chambert K, Belliveau RA, Forty L, Gordon-Smith K, Di Florio A, Lee PH, Bromet EJ, Buckley PF, Escamilla MA, Fanous AH, Fochtmann LJ, Lehrer DS, Malaspina D, Marder SR, Morley CP, Nicolini H, Perkins DO, Rakofsky JJ, Rapaport MH, Medeiros H, Sobell JL, Green EK, Backlund L, Bergen SE, Juréus A, Schalling M, Lichtenstein P, Roussos P, Knowles JA, Jones I, Jones LA, Hultman CM, Perlis RH, Purcell SM, McCarroll SA, Pato CN, Pato MT, Craddock N, Landén M, Smoller JW, Sklar P.

Transl Psychiatry. 2017 Jan 10;7(1):e993. doi: 10.1038/tp.2016.242.

5.

Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study.

Montano C, Taub MA, Jaffe A, Briem E, Feinberg JI, Trygvadottir R, Idrizi A, Runarsson A, Berndsen B, Gur RC, Moore TM, Perry RT, Fugman D, Sabunciyan S, Yolken RH, Hyde TM, Kleinman JE, Sobell JL, Pato CN, Pato MT, Go RC, Nimgaonkar V, Weinberger DR, Braff D, Gur RE, Fallin MD, Feinberg AP.

JAMA Psychiatry. 2016 May 1;73(5):506-14. doi: 10.1001/jamapsychiatry.2016.0144.

6.

Substance use associated with short sleep duration in patients with schizophrenia or schizoaffective disorder.

Tang VK, Pato MT, Sobell JL, Hammond TC, Valdez MM, Lane CJ; Genomic Psychiatry Cohort Consortium, Pato CN.

Am J Med Genet B Neuropsychiatr Genet. 2016 Jun;171(4):525-33. doi: 10.1002/ajmg.b.32374. Epub 2015 Sep 8.

PMID:
26345478
7.

Traumatic brain injury and bipolar psychosis in the Genomic Psychiatry Cohort.

Cieslak K, Pato M, Buckley P, Pato C, Sobell JL, Medeiros H, Zhao Y, Ahn H; Genomic Psychiatry Cohort Consortium, Malaspina D.

Am J Med Genet B Neuropsychiatr Genet. 2016 Jun;171(4):506-12. doi: 10.1002/ajmg.b.32350. Epub 2015 Jul 29.

PMID:
26224022
8.

Paternal age effect: Replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis.

Lehrer DS, Pato MT, Nahhas RW, Miller BR, Malaspina D, Buckley PF, Sobell JL, Walsh-Messinger J, Genomic Psychiatry Cohort Consortium, Pato CN.

Am J Med Genet B Neuropsychiatr Genet. 2016 Jun;171(4):495-505. doi: 10.1002/ajmg.b.32334. Epub 2015 Jul 16.

PMID:
26183902
9.

Comorbidity of severe psychotic disorders with measures of substance use.

Hartz SM, Pato CN, Medeiros H, Cavazos-Rehg P, Sobell JL, Knowles JA, Bierut LJ, Pato MT; Genomic Psychiatry Cohort Consortium.

JAMA Psychiatry. 2014 Mar;71(3):248-54. doi: 10.1001/jamapsychiatry.2013.3726.

10.

The genomic psychiatry cohort: partners in discovery.

Pato MT, Sobell JL, Medeiros H, Abbott C, Sklar BM, Buckley PF, Bromet EJ, Escamilla MA, Fanous AH, Lehrer DS, Macciardi F, Malaspina D, McCarroll SA, Marder SR, Moran J, Morley CP, Nicolini H, Perkins DO, Purcell SM, Rapaport MH, Sklar P, Smoller JW, Knowles JA; Genomic Psychiatry Cohort Consortium, Pato CN.

Am J Med Genet B Neuropsychiatr Genet. 2013 Jun;162B(4):306-12. doi: 10.1002/ajmg.b.32160. Epub 2013 May 3.

11.

Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples.

Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier DA, Cordeiro Q, Corvin AP, Deshpande SN, Egan MF, Gill M, Kendler KS, Kirov G, Heston LL, Levitt P, Lewis DA, Li T, Mirnics K, Morris DW, Norton N, O'Donovan MC, Owen MJ, Richard C, Semwal P, Sobell JL, St Clair D, Straub RE, Thelma BK, Vallada H, Weinberger DR, Williams NM, Wood J, Zhang F, Devlin B, Nimgaonkar VL.

Biol Psychiatry. 2006 Jul 15;60(2):152-62. Epub 2006 Apr 21. Review.

12.

Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians.

Sobell JL, Richard C, Wirshing DA, Heston LL.

Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5;139B(1):23-7.

PMID:
16082709
13.

The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study.

Heit JA, Sobell JL, Li H, Sommer SS.

J Thromb Haemost. 2005 Feb;3(2):305-11.

14.

Multiple missense mutations in the diazepam binding inhibitor (DBI) gene identified in schizophrenia but lack of disease association.

Niu N, Rice SR, Heston LL, Sobell JL.

Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):10-9.

PMID:
14755437
15.

Genetics and etiopathophysiology of schizophrenia.

Sobell JL, Mikesell MJ, McMurray CT.

Mayo Clin Proc. 2002 Oct;77(10):1068-82. Review.

PMID:
12374251
16.

Alteration of branch site consensus sequence and enhanced pre-mRNA splicing of an NMDAR1 intron not associated with schizophrenia.

Hammond L, Castanotto D, Rice SR, Nimgaonkar VL, Wirshing DA, Rossi JJ, Heston LL, Sobell JL.

Am J Med Genet. 2002 Aug 8;114(6):631-6.

PMID:
12210277
18.

Histamine N-methyltransferase functional polymorphism: lack of association with schizophrenia.

Yan L, Szumlanski CL, Rice SR, Sobell JL, Lachman HM, Weinshilboum RM.

Am J Med Genet. 2000 Jun 12;96(3):404-6.

PMID:
10898922
19.

Variants in the alpha2A AR adrenergic receptor gene in psychiatric patients.

Feng J, Sobell JL, Heston LL, Goldman D, Cook E Jr, Kranzler HR, Gelernter J, Sommer SS.

Am J Med Genet. 1998 Sep 7;81(5):405-10.

PMID:
9754626
20.

Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid.

Feng J, Sobell JL, Heston LL, Cook EH Jr, Goldman D, Sommer SS.

Am J Med Genet. 1998 Mar 28;81(2):172-8.

PMID:
9613858
21.

Gly(247)-->Asp proenkephalin A mutation is rare in schizophrenia populations.

Mikesell MJ, Barron YD, Nimgaonkar VL, Sobell JL, Sommer SS, McMurray CT.

Am J Med Genet. 1997 Apr 18;74(2):213-5.

PMID:
9129728
23.

Identification of a missense mutation and several polymorphisms in the proenkephalin A gene of schizophrenic patients.

Mikesell MJ, Sobell JL, Sommer SS, McMurray CT.

Am J Med Genet. 1996 Sep 20;67(5):459-67.

PMID:
8886162
24.

Genotype-to-phenotype analysis: search for clinical characteristics of a missense change in the GABAA-beta 1 receptor gene.

Sobell JL, Sigurdson DC, Heston LL, Byerley WF, Sommer SS.

Am J Med Genet. 1996 Feb 16;67(1):81-4.

PMID:
8678120
26.

The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease.

Sobell JL, Lind TJ, Sigurdson DC, Zald DH, Snitz BE, Grove WM, Heston LL, Sommer SS.

Hum Mol Genet. 1995 Apr;4(4):507-14.

PMID:
7633397
27.

Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989.

Anía BJ, Suman VJ, Sobell JL, Codd MB, Silverstein MN, Melton LJ 3rd.

Am J Hematol. 1994 Oct;47(2):89-93.

PMID:
8092146
28.

Screening the dystrophin gene suggests a high rate of polymorphism in general but no exonic deletions in schizophrenics.

Lindor NM, Sobell JL, Heston LL, Thibodeau SN, Sommer SS.

Am J Med Genet. 1994 Mar 15;54(1):1-4.

PMID:
7909988
29.

A common exonic polymorphism in the human D5 dopamine receptor gene.

Sommer SS, Sobell JL, Heston LL.

Hum Genet. 1993 Dec;92(6):633-4. No abstract available.

PMID:
8262527
30.

APP mutations and schizophrenia.

Arnholt JC, Sobell JL, Heston LL, Sommer SS.

Biol Psychiatry. 1993 Nov 15;34(10):739-40. No abstract available.

PMID:
8292675
31.

Dopamine D4 receptor variants in unrelated schizophrenic cases and controls.

Sommer SS, Lind TJ, Heston LL, Sobell JL.

Am J Med Genet. 1993 Jul 15;48(2):90-3.

PMID:
8103294
32.
33.

Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility.

Sobell JL, Heston LL, Sommer SS.

Genomics. 1992 Jan;12(1):1-6. Review. No abstract available.

PMID:
1733846
34.
35.

A novel method for detecting point mutations or polymorphisms and its application to population screening for carriers of phenylketonuria.

Sommer SS, Cassady JD, Sobell JL, Bottema CD.

Mayo Clin Proc. 1989 Nov;64(11):1361-72. Review.

PMID:
2687596
36.

Application of DNA-based diagnosis to patient care: the example of hemophilia A.

Sommer SS, Sobell JL.

Mayo Clin Proc. 1987 May;62(5):387-404. Review.

PMID:
3553754

Supplemental Content

Loading ...
Support Center